| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/08/2004 | WO2004029043A1 Pyrazole compounds |
| 04/08/2004 | WO2004029041A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | WO2004028463A2 Methods and compositions for the treatment of lupus using clofarabine |
| 04/08/2004 | WO2004028243A2 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 04/08/2004 | WO2004028239A2 Mammal model for autoimmune diseases with dysfunction of socs-1 gene |
| 04/08/2004 | WO2004015096A3 Leech extracts for stents |
| 04/08/2004 | WO2004011444A3 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 04/08/2004 | WO2004005350A3 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 04/08/2004 | WO2003105775A3 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 04/08/2004 | WO2003105769A3 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 04/08/2004 | WO2003103709A3 Cd200-receptor mediated modulation of bone development |
| 04/08/2004 | WO2003102207A3 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084979A3 Novel peptides and the application thereof in therapy |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003076602A3 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
| 04/08/2004 | WO2003076455A3 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003053158A9 Malleable protein matrix and uses thereof |
| 04/08/2004 | WO2003047519A3 'compressed annular tablet with molded triturate tablet for oral and intraoral' |
| 04/08/2004 | WO2003022123A9 Methods of kidney transplantation utilizing developing nephric tissue |
| 04/08/2004 | WO2003018606A9 Casein derived peptides and uses thereof in therapy |
| 04/08/2004 | WO2003013599A3 Anti-coronavirus vaccine |
| 04/08/2004 | WO2003011313A8 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 04/08/2004 | WO2002083854A3 Antibodies to vla-1 |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068108 Disaccharide sequences formed by uronic acid and hexose as to form polysaccharides of 8-24 monosaccharide units whose hydroxyl groups are substituted by alkyl or sulphate groups; possible to modulate activities of glycosaminoglycans type |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067987 Antiarthritic agents; osteoporosis; anticancer agents |
| 04/08/2004 | US20040067975 Amido ether substituted imidazoquinolines |
| 04/08/2004 | US20040067971 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/08/2004 | US20040067969 Syntheses of quinazolinones |
| 04/08/2004 | US20040067959 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067951 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof |
| 04/08/2004 | US20040067949 Substituted indoles which are parp inhibitors |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067943 Tryptase inhibitors |
| 04/08/2004 | US20040067941 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067930 Central nervous system disorders; neurotransmitters; side effect reduction |
| 04/08/2004 | US20040067923 Use of biogenic estriol sulfamate prodrugs for treatment of autoimmune diseases |
| 04/08/2004 | US20040067910 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 04/08/2004 | US20040067888 Nucleic acid capable of binding to interferons |
| 04/08/2004 | US20040067527 A conjugate of an acrylamide based polymer, capable of being taken up by a cell, linked to a biologically active polypeptides and conjugate capable of intracellular delivery of polypeptide while retaining its activity |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/08/2004 | US20040067515 Human proteinase molecules |
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067236 In combination with a Th1-inducing adjuvant; vaccines |
| 04/08/2004 | US20040067232 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 04/08/2004 | US20040067218 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissue |
| 04/08/2004 | CA2500091A1 Methods and compositions for the treatment of lupus using clofarabine |
| 04/08/2004 | CA2498826A1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 04/08/2004 | CA2497765A1 8-hydroxy substituted adenine compounds and uses thereof |
| 04/08/2004 | CA2497280A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | CA2496761A1 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 04/07/2004 | EP1405862A2 Method for the identification of antigenic peptides |
| 04/07/2004 | EP1405855A1 A kind of oligosaccharides, their sulfates and dendrimers, and the uses of these compounds |
| 04/07/2004 | EP1405844A1 Cycloalkenone derivative |
| 04/07/2004 | EP1405645A1 Remedies for eosinophilic diseases |
| 04/07/2004 | EP1405643A1 Acellular pertussis vaccines and methods of preparation thereof |
| 04/07/2004 | EP1405640A1 Novel immunosuppressants |
| 04/07/2004 | EP1405560A1 Il-18 transgenic animal |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404873A2 Chimeric immunomodulatory compounds and methods of using the same |
| 04/07/2004 | EP1404841A2 Cyp1b1 nucleic acids and methods of use |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404811A2 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 04/07/2004 | EP1404715A2 Modified cd8 molecule, nucleic acid encoding said molecule, and their therapeutic use |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404682A1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48 |
| 04/07/2004 | EP1404679A2 (hetero)aryl substituted benzofurans as 5-ht ligands |
| 04/07/2004 | EP1404676A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404656A1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |
| 04/07/2004 | EP1404652A1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404367A2 Use of polyclonal anti-hiv goat serum as a therapeutic agent |
| 04/07/2004 | EP1404362A2 Signal-1/signal-2 bifunctional peptide inhibitors |
| 04/07/2004 | EP1404359A2 Methods of treatment involving human mda-7 |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404323A1 Use of methylnaltrexone to treat immune suppression |
| 04/07/2004 | EP1404322A2 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof |
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP1404315A1 Synergistic compositions of n-acylhomoserine lactones and 4-quinolones |
| 04/07/2004 | EP1404314A1 Aerosol formulations of delta 8 tetrahydrocannabinol |
| 04/07/2004 | EP1404302A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 04/07/2004 | EP1404295A2 Sustained release drug delivery devices with coated drug cores |
| 04/07/2004 | EP1240132B1 Adamantane derivatives |